<DOC>
	<DOCNO>NCT00273767</DOCNO>
	<brief_summary>The main objective observe effect erythropoietin administration different blood marker ischaemic cardiac lesion induce cardiopulmonary bypass .</brief_summary>
	<brief_title>Preliminary Administration EPO Markers Cardiac Ischemia Induced CPB</brief_title>
	<detailed_description>A new property erythropoietin ( EPO ) , independent hematopoietic role , recently discover . Indeed , report hormone , follow bind cardiac cerebral receptor , able induce spectacular cellular protection ischemic injury . These cardioprotective neuroprotective effect observe experimentally rodent well clinically human . In particular , team demonstrate administration NeoRecormon® protect heart ischemia rat significantly improve recovery . In view excite experimental result grow interest scientific community cytoprotective effect EPO , plan first clinical study examine cardiac cerebral protective effect EPO ( NeoRecormon® ) set cardiac surgery .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Coronary bypass surgery . Surgery urgent . Left ventricular ejection fraction ( LVEF ) &gt; 40 . Informed consent form sign . Valvular surgery . Surgery beat heart , without cardiopulmonary bypass . Carotid bypass surgery . Myocardial infarction le 30 day . Previous history cardiac surgery . Kidney failure ( creatinine &gt; 200 µmol/l ) . Uncontrolled hypertension . Unstable angina . Risk deep venous thrombosis . Vascular cerebral attack le 30 day . Malignant tumour . Phenylketonuria . Allergy erythropoietin . Previous program blood donation . Pregnancy feeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>troponin T</keyword>
	<keyword>CK-MB</keyword>
	<keyword>protein S-100</keyword>
	<keyword>Cardiopulmonary Bypass</keyword>
	<keyword>Erythropoietin</keyword>
</DOC>